There were 859 press releases posted in the last 24 hours and 166,807 in the last 365 days.

Global Anemia Drugs Industry

Anemia Drugs market worldwide is projected to grow by US$18. 9 Billion, driven by a compounded growth of 8%. Iron Deficiency Anemia, one of the segments analyzed and sized in this study, displays the potential to grow at over 8.

/EIN News/ -- New York, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Anemia Drugs Industry" - https://www.reportlinker.com/p05817966/?utm_source=GNW
8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$19.3 Billion by the year 2025, Iron Deficiency Anemia will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 6.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$651.7 Million to the region’s size and clout in the next 5 to 6 years. Over US$563.5 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Iron Deficiency Anemia will reach a market size of US$923.4 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 12% over the next couple of years and add approximately US$5.4 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, Acceleron Pharma, Inc.; Amgen, Inc.; Bayer AG; Biocon Ltd.; bluebird bio, Inc.; Eli Lilly and Company; GlaxoSmithKline PLC; GlycoMimetics, Inc.; Regen Biopharma Inc.


Read the full report: https://www.reportlinker.com/p05817966/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Anemia Drugs Competitor Market Share Scenario Worldwide (in %):
2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Anemia Drugs Global Market Estimates and Forecasts in
US$ Million by Region/Country: 2018-2025
Table 2: Anemia Drugs Global Retrospective Market Scenario in
US$ Million by Region/Country: 2009-2017
Table 3: Anemia Drugs Market Share Shift across Key Geographies
Worldwide: 2009 VS 2019 VS 2025
Table 4: Iron Deficiency Anemia (Type) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 5: Iron Deficiency Anemia (Type) Historic Market Analysis
by Region/Country in US$ Million: 2009 to 2017
Table 6: Iron Deficiency Anemia (Type) Market Share Breakdown
of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Table 7: Sickle Cell Anemia (Type) Potential Growth Markets
Worldwide in US$ Million: 2018 to 2025
Table 8: Sickle Cell Anemia (Type) Historic Market Perspective
by Region/Country in US$ Million: 2009 to 2017
Table 9: Sickle Cell Anemia (Type) Market Sales Breakdown by
Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 10: Aplastic Anemia (Type) Geographic Market Spread
Worldwide in US$ Million: 2018 to 2025
Table 11: Aplastic Anemia (Type) Region Wise Breakdown of
Global Historic Demand in US$ Million: 2009 to 2017
Table 12: Aplastic Anemia (Type) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 13: Hemolytic Anemia (Type) World Market Estimates and
Forecasts by Region/Country in US$ Million: 2018 to 2025
Table 14: Hemolytic Anemia (Type) Market Historic Review by
Region/Country in US$ Million: 2009 to 2017
Table 15: Hemolytic Anemia (Type) Market Share Breakdown by
Region/Country: 2009 VS 2019 VS 2025
Table 16: Pernicious Anemia (Type) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 17: Pernicious Anemia (Type) Historic Market Analysis by
Region/Country in US$ Million: 2009 to 2017
Table 18: Pernicious Anemia (Type) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 19: Other Types (Type) World Market Estimates and
Forecasts in US$ Million by Region/Country: 2018 to 2025
Table 20: Other Types (Type) Market Worldwide Historic Review
by Region/Country in US$ Million: 2009 to 2017
Table 21: Other Types (Type) Market Percentage Share
Distribution by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Anemia Drugs Market Share (in %) by Company: 2019 & 2025
Table 22: United States Anemia Drugs Market Estimates and
Projections in US$ Million by Type: 2018 to 2025
Table 23: Anemia Drugs Market in the United States by Type: A
Historic Review in US$ Million for 2009-2017
Table 24: United States Anemia Drugs Market Share Breakdown by
Type: 2009 VS 2019 VS 2025
CANADA
Table 25: Canadian Anemia Drugs Market Estimates and Forecasts
in US$ Million by Type: 2018 to 2025
Table 26: Canadian Anemia Drugs Historic Market Review by Type
in US$ Million: 2009-2017
Table 27: Anemia Drugs Market in Canada: Percentage Share
Breakdown of Sales by Type for 2009, 2019, and 2025
JAPAN
Table 28: Japanese Market for Anemia Drugs: Annual Sales
Estimates and Projections in US$ Million by Type for the Period
2018-2025
Table 29: Anemia Drugs Market in Japan: Historic Sales Analysis
in US$ Million by Type for the Period 2009-2017
Table 30: Japanese Anemia Drugs Market Share Analysis by Type:
2009 VS 2019 VS 2025
CHINA
Table 31: Chinese Anemia Drugs Market Growth Prospects in US$
Million by Type for the Period 2018-2025
Table 32: Anemia Drugs Historic Market Analysis in China in US$
Million by Type: 2009-2017
Table 33: Chinese Anemia Drugs Market by Type: Percentage
Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Anemia Drugs Market: Competitor Market Share Scenario
(in %) for 2019 & 2025
Table 34: European Anemia Drugs Market Demand Scenario in US$
Million by Region/Country: 2018-2025
Table 35: Anemia Drugs Market in Europe: A Historic Market
Perspective in US$ Million by Region/Country for the Period
2009-2017
Table 36: European Anemia Drugs Market Share Shift by
Region/Country: 2009 VS 2019 VS 2025
Table 37: European Anemia Drugs Market Estimates and Forecasts
in US$ Million by Type: 2018-2025
Table 38: Anemia Drugs Market in Europe in US$ Million by Type:
A Historic Review for the Period 2009-2017
Table 39: European Anemia Drugs Market Share Breakdown by Type:
2009 VS 2019 VS 2025
FRANCE
Table 40: Anemia Drugs Market in France by Type: Estimates and
Projections in US$ Million for the Period 2018-2025
Table 41: French Anemia Drugs Historic Market Scenario in US$
Million by Type: 2009-2017
Table 42: French Anemia Drugs Market Share Analysis by Type:
2009 VS 2019 VS 2025
GERMANY
Table 43: Anemia Drugs Market in Germany: Recent Past, Current
and Future Analysis in US$ Million by Type for the Period
2018-2025
Table 44: German Anemia Drugs Historic Market Analysis in US$
Million by Type: 2009-2017
Table 45: German Anemia Drugs Market Share Breakdown by Type:
2009 VS 2019 VS 2025
ITALY
Table 46: Italian Anemia Drugs Market Growth Prospects in US$
Million by Type for the Period 2018-2025
Table 47: Anemia Drugs Historic Market Analysis in Italy in US$
Million by Type: 2009-2017
Table 48: Italian Anemia Drugs Market by Type: Percentage
Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
Table 49: United Kingdom Market for Anemia Drugs: Annual Sales
Estimates and Projections in US$ Million by Type for the Period
2018-2025
Table 50: Anemia Drugs Market in the United Kingdom: Historic
Sales Analysis in US$ Million by Type for the Period 2009-2017
Table 51: United Kingdom Anemia Drugs Market Share Analysis by
Type: 2009 VS 2019 VS 2025
SPAIN
Table 52: Spanish Anemia Drugs Market Estimates and Forecasts
in US$ Million by Type: 2018 to 2025
Table 53: Spanish Anemia Drugs Historic Market Review by Type
in US$ Million: 2009-2017
Table 54: Anemia Drugs Market in Spain: Percentage Share
Breakdown of Sales by Type for 2009, 2019, and 2025
RUSSIA
Table 55: Russian Anemia Drugs Market Estimates and Projections
in US$ Million by Type: 2018 to 2025
Table 56: Anemia Drugs Market in Russia by Type: A Historic
Review in US$ Million for 2009-2017
Table 57: Russian Anemia Drugs Market Share Breakdown by Type:
2009 VS 2019 VS 2025
REST OF EUROPE
Table 58: Rest of Europe Anemia Drugs Market Estimates and
Forecasts in US$ Million by Type: 2018-2025
Table 59: Anemia Drugs Market in Rest of Europe in US$ Million
by Type: A Historic Review for the Period 2009-2017
Table 60: Rest of Europe Anemia Drugs Market Share Breakdown by
Type: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 61: Asia-Pacific Anemia Drugs Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 62: Anemia Drugs Market in Asia-Pacific: Historic Market
Analysis in US$ Million by Region/Country for the Period
2009-2017
Table 63: Asia-Pacific Anemia Drugs Market Share Analysis by
Region/Country: 2009 VS 2019 VS 2025
Table 64: Anemia Drugs Market in Asia-Pacific by Type:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 65: Asia-Pacific Anemia Drugs Historic Market Scenario in
US$ Million by Type: 2009-2017
Table 66: Asia-Pacific Anemia Drugs Market Share Analysis by
Type: 2009 VS 2019 VS 2025
AUSTRALIA
Table 67: Anemia Drugs Market in Australia: Recent Past,
Current and Future Analysis in US$ Million by Type for the
Period 2018-2025
Table 68: Australian Anemia Drugs Historic Market Analysis in
US$ Million by Type: 2009-2017
Table 69: Australian Anemia Drugs Market Share Breakdown by
Type: 2009 VS 2019 VS 2025
INDIA
Table 70: Indian Anemia Drugs Market Estimates and Forecasts in
US$ Million by Type: 2018 to 2025
Table 71: Indian Anemia Drugs Historic Market Review by Type in
US$ Million: 2009-2017
Table 72: Anemia Drugs Market in India: Percentage Share
Breakdown of Sales by Type for 2009, 2019, and 2025
SOUTH KOREA
Table 73: Anemia Drugs Market in South Korea: Recent Past,
Current and Future Analysis in US$ Million by Type for the
Period 2018-2025
Table 74: South Korean Anemia Drugs Historic Market Analysis in
US$ Million by Type: 2009-2017
Table 75: Anemia Drugs Market Share Distribution in South Korea
by Type: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 76: Rest of Asia-Pacific Market for Anemia Drugs: Annual
Sales Estimates and Projections in US$ Million by Type for the
Period 2018-2025
Table 77: Anemia Drugs Market in Rest of Asia-Pacific: Historic
Sales Analysis in US$ Million by Type for the Period 2009-2017
Table 78: Rest of Asia-Pacific Anemia Drugs Market Share
Analysis by Type: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 79: Latin American Anemia Drugs Market Trends by
Region/Country in US$ Million: 2018-2025
Table 80: Anemia Drugs Market in Latin America in US$ Million
by Region/Country: A Historic Perspective for the Period
2009-2017
Table 81: Latin American Anemia Drugs Market Percentage
Breakdown of Sales by Region/Country: 2009, 2019, and 2025
Table 82: Latin American Anemia Drugs Market Growth Prospects
in US$ Million by Type for the Period 2018-2025
Table 83: Anemia Drugs Historic Market Analysis in Latin
America in US$ Million by Type: 2009-2017
Table 84: Latin American Anemia Drugs Market by Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
ARGENTINA
Table 85: Argentinean Anemia Drugs Market Estimates and
Forecasts in US$ Million by Type: 2018-2025
Table 86: Anemia Drugs Market in Argentina in US$ Million by
Type: A Historic Review for the Period 2009-2017
Table 87: Argentinean Anemia Drugs Market Share Breakdown by
Type: 2009 VS 2019 VS 2025
BRAZIL
Table 88: Anemia Drugs Market in Brazil by Type: Estimates and
Projections in US$ Million for the Period 2018-2025
Table 89: Brazilian Anemia Drugs Historic Market Scenario in
US$ Million by Type: 2009-2017
Table 90: Brazilian Anemia Drugs Market Share Analysis by Type:
2009 VS 2019 VS 2025
MEXICO
Table 91: Anemia Drugs Market in Mexico: Recent Past, Current
and Future Analysis in US$ Million by Type for the Period
2018-2025
Table 92: Mexican Anemia Drugs Historic Market Analysis in US$
Million by Type: 2009-2017
Table 93: Mexican Anemia Drugs Market Share Breakdown by Type:
2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 94: Rest of Latin America Anemia Drugs Market Estimates
and Projections in US$ Million by Type: 2018 to 2025
Table 95: Anemia Drugs Market in Rest of Latin America by Type:
A Historic Review in US$ Million for 2009-2017
Table 96: Rest of Latin America Anemia Drugs Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 97: The Middle East Anemia Drugs Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 98: Anemia Drugs Market in the Middle East by
Region/Country in US$ Million: 2009-2017
Table 99: The Middle East Anemia Drugs Market Share Breakdown
by Region/Country: 2009, 2019, and 2025
Table 100: The Middle East Anemia Drugs Market Estimates and
Forecasts in US$ Million by Type: 2018 to 2025
Table 101: The Middle East Anemia Drugs Historic Market by
Type in US$ Million: 2009-2017
Table 102: Anemia Drugs Market in the Middle East: Percentage
Share Breakdown of Sales by Type for 2009, 2019, and 2025
IRAN
Table 103: Iranian Market for Anemia Drugs: Annual Sales
Estimates and Projections in US$ Million by Type for the Period
2018-2025
Table 104: Anemia Drugs Market in Iran: Historic Sales Analysis
in US$ Million by Type for the Period 2009-2017
Table 105: Iranian Anemia Drugs Market Share Analysis by Type:
2009 VS 2019 VS 2025
ISRAEL
Table 106: Israeli Anemia Drugs Market Estimates and Forecasts
in US$ Million by Type: 2018-2025
Table 107: Anemia Drugs Market in Israel in US$ Million by
Type: A Historic Review for the Period 2009-2017
Table 108: Israeli Anemia Drugs Market Share Breakdown by Type:
2009 VS 2019 VS 2025
SAUDI ARABIA
Table 109: Saudi Arabian Anemia Drugs Market Growth Prospects
in US$ Million by Type for the Period 2018-2025
Table 110: Anemia Drugs Historic Market Analysis in Saudi
Arabia in US$ Million by Type: 2009-2017
Table 111: Saudi Arabian Anemia Drugs Market by Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED ARAB EMIRATES
Table 112: Anemia Drugs Market in the United Arab Emirates:
Recent Past, Current and Future Analysis in US$ Million by Type
for the Period 2018-2025
Table 113: United Arab Emirates Anemia Drugs Historic Market
Analysis in US$ Million by Type: 2009-2017
Table 114: Anemia Drugs Market Share Distribution in United
Arab Emirates by Type: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
Table 115: Anemia Drugs Market in Rest of Middle East: Recent
Past, Current and Future Analysis in US$ Million by Type for
the Period 2018-2025
Table 116: Rest of Middle East Anemia Drugs Historic Market
Analysis in US$ Million by Type: 2009-2017
Table 117: Rest of Middle East Anemia Drugs Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
AFRICA
Table 118: African Anemia Drugs Market Estimates and
Projections in US$ Million by Type: 2018 to 2025
Table 119: Anemia Drugs Market in Africa by Type: A Historic
Review in US$ Million for 2009-2017
Table 120: African Anemia Drugs Market Share Breakdown by Type:
2009 VS 2019 VS 2025

IV. COMPETITION

ACCELERON PHARMA
AMGEN
BAYER AG
BIOCON
BLUEBIRD BIO
ELI LILLY AND COMPANY
GLAXOSMITHKLINE PLC
GLYCOMIMETICS, INC.
REGEN BIOPHARMA INC.

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05817966/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
Distribution channels: Media, Advertising & PR


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.